ARTICLE

INHIBITION OF MYOBLAST FUSION AFTER ONE ROUND OF DNA SYNTHESIS IN 5-BROMODEOXYURIDINE

Richard Bischoff ¹ and Howard Holtzer ¹

¹ From the Department of Anatomy, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104.

Dr. Bischoff's present address is the Department of Anatomy, School of Medicine, Washington University, St. Louis, Missouri 63110

The thymidine analogue 5-bromodeoxyuridine (BUdR) has a differential effect on the synthesis of tissue-specific products and molecules required for growth and division. Proliferating myogenic cells cultured in BUdR fail to fuse and fail to initiate the synthesis of contractile protein filaments. Conversely, BUdR has but a minor effect on cell viability and reproductive integrity. Low concentrations of BUdR result in an enhancement of cell number relative to the controls; higher concentrations are cytotoxic. Suppression of myogenesis is reversible after at least 10 cell generations of growth in the analogue. Cells that do not synthesize DNA, such as postmitotic myoblasts and myotubes, are not affected by BUdR. Incorporation of BUdR for one round of DNA synthesis was accomplished by first incubating myogenic cells, prior to fusion, in 5-fluorodeoxyuridine (FUdR) to block DNA synthesis and collect cells in the presynthetic phase. The cells were then allowed to synthesize either normal DNA or BU-DNA for one S period by circumventing the FUdR block with BUdR or BUdR plus thymidine (TdR). The cultures were continued in FUdR to prevent dilution of the incorporated analogue by further division. After 3 days, the cultures from the FUdR-BUdR series showed the typical BUdR effect; the cells were excessively flattened and few multinucleated myotubes formed. Cells in the control cultures were of normal morphology, and multinucleated myotubes were present. These results were confirmed in another experiment in which BUdR-³H was added to 2-day cultures in which myotubes were forming. Fusion of thymidine-³H-labeled cells begins at 8 hr after the preceding S phase. In contrast, cells which incorporate BUdR-³H for one S period do not fuse with normal myotubes.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Zammit, P. S. (2008). All muscle satellite cells are equal, but are some more equal than others?. J. Cell Sci. 121: 2975-2982 [Abstract] [Full Text]  
• Smith, H. K., Maxwell, L., Rodgers, C. D., McKee, N. H., Plyley, M. J. (2001). Exercise-enhanced satellite cell proliferation and new myonuclear accretion in rat skeletal muscle. J. Appl. Physiol. 90: 1407-1414 [Abstract] [Full Text]  
• Reome, J. B., Johnston, D. S., Helmich, B. K., Morgan, T. M., Dutton-Swain, N., Dutton, R. W. (2000). The Effects of Prolonged Administration of 5-Bromodeoxyuridine on Cells of the Immune System. J. Immunol. 165: 4226-4230 [Abstract] [Full Text]  
• Weintraub, H, Davis, R, Tapscott, S, Thayer, M, Krause, M, Benezra, R, Blackwell, T., Turner, D, Rupp, R, Hollenberg, S, et, al. (1991). The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251: 761-766 [Abstract]  
• Tapscott, S., Lassar, A., Davis, R., Weintraub, H (1989). 5-bromo-2'-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1. Science 245: 532-536 [Abstract]  
• Lin, Z Y, Dechesne, C A, Eldridge, J, Paterson, B M (1989). An avian muscle factor related to MyoD1 activates muscle-specific promoters in nonmuscle cells of different germ-layer origin and in BrdU-treated myoblasts.. Genes Dev. 3: 986-996 [Abstract]  
• Holtzer, H., Sanger, J. W., Ishikawa, H., Strahs, K. (1973). Selected Topics in Skeletal Myogenesis. Cold Spring Harb Symp Quant Biol 37: 549-566 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents